Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours ยท Estimated delivery Aug 11 - Aug 16
Exploration of microbiota targets for major depressive disorder and mood related traits
Within safe limits, yes
Why your prescription purpose doesnt disqualify you: The injury is the same whether you took the drug for diabetes or weight loss The warnings were inadequate for both approved uses The mechanism is identical regardless of indication The failure to warn affected all patients, not just one category In fact, diabetes patients may have stronger arguments: You needed the medication for a serious health condition You had fewer alternatives available The risk-benefit calculation was different You were a captive market with less choice Your claim will focus on: Whether you were adequately informed of gastroparesis risk Whether the severity and potential permanence were disclosed Whether you would have chosen differently if properly warned The damages you suffered as a result Q: What if I took multiple GLP-1 drugs over time
Your online ads will appear above organic search results and a map of nearby businesses
GLP-1-based therapies such as liraglutide, semaglutide, and tirzepatide are widely used to treat T2D and obesity
& Mason, P
